--- title: "LFTD PARTNERS INC. (LIFD) stock: news and investor profile" url: "https://aibio.space/companies/lftd-partners/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "LFTD PARTNERS INC. (OTC: LIFD), United States. Listing facts, related biotech companies and news on aibio.space." --- LIFD LFTD PARTNERS INC. OTC · United States # LFTD PARTNERS INC. (LIFD) news LFTD PARTNERS INC. is a public biotech or pharmaceutical company listed on OTC under the ticker LIFD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest LFTD PARTNERS INC. news We have not published a story on LFTD PARTNERS INC. yet. When there is news, it will appear here. ## LFTD PARTNERS INC. at a glance - **Ticker**: LIFD - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $1.5 million ### Related companies - [CareDx](https://aibio.space/companies/caredx/) NASDAQ: CDNA - [InfuSystem Holdings](https://aibio.space/companies/infusystem/) NYSE: INFU - [RadNet](https://aibio.space/companies/radnet/) NASDAQ: RDNT - [Polomar Health Services](https://aibio.space/companies/polomar-health-services/) OTC: PMHS - [Edwards Lifesciences](https://aibio.space/companies/edwards-lifesciences/) NYSE: EW - [ACCURAY INC](https://aibio.space/companies/accuray/) NASDAQ: ARAY - [Envoy Medical](https://aibio.space/companies/envoy-medical/) NASDAQ: COCH - [Revium Rx.](https://aibio.space/companies/revium-rx/) OTC: RVRC ### Also on OTC - [Vireo Growth](https://aibio.space/companies/vireo-growth/) VREOF - [HARD TO TREAT DISEASES INC](https://aibio.space/companies/hard-to-treat-diseases/) HTDS - [Beroni Group](https://aibio.space/companies/beroni/) BNIGF - [Vicarious Surgical](https://aibio.space/companies/vicarious-surgical/) RBOT - [Aridis Pharmaceuticals](https://aibio.space/companies/aridis-pharmaceuticals/) ARDS - [GELSTAT CORP](https://aibio.space/companies/gelstat/) GSAC ## LFTD PARTNERS INC. annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$36.9 million](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | [$37.3 million](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | | Net income (loss) | [-$24.9 million](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | [-$1.9 million](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | | Cash from operations | [$1.3 million](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | [-$960,067](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | | Cash and equivalents | [$1.8 million](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | [$2.1 million](https://www.sec.gov/Archives/edgar/data/1391135/000109690626000454/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $1.5 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about LFTD PARTNERS INC. What is the ticker symbol of LFTD PARTNERS INC.? LFTD PARTNERS INC. trades under the ticker LIFD on OTC. Where is LFTD PARTNERS INC. listed? LFTD PARTNERS INC. is listed on OTC. Which country or territory is LFTD PARTNERS INC. listed under? Our directory records LFTD PARTNERS INC. under United States. Does aibio.space cover LFTD PARTNERS INC.? aibio.space lists LFTD PARTNERS INC. among 2,820 public biotech companies and publishes its news here as stories appear. What was LFTD PARTNERS INC.'s revenue last year? $36.9 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is LFTD PARTNERS INC. profitable? LFTD PARTNERS INC. reported a net loss of $24.9 million for the fiscal year ended Dec 31, 2025, and generated $1.3 million of cash from operations, per its annual report to the SEC. How much cash does LFTD PARTNERS INC. have? $1.5 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: LFTD PARTNERS INC. Members talk about LFTD PARTNERS INC. (LIFD). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at LFTD PARTNERS INC., newest first. Each line links the filing it comes from. 1. 2026-10-01 Mergers Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.02,2.01,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1391135/000109690626001491/lifd_ex99z1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:LIFD on TradingView](https://www.tradingview.com/symbols/OTC-LIFD/). ## Listing details LFTD PARTNERS INC. is a public biotech or pharmaceutical company listed on OTC under the ticker LIFD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: LFTD PARTNERS INC. - **Ticker**: LIFD - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/lftd-partners/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "LFTD PARTNERS INC. (LIFD) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/lftd-partners/